safety of glp-1 receptor agonists and Research to Treat Overeating and Substance Use Disorders GLP1 receptor agonists are supported

Bentebibel SE, McGrail DJ, Kochat V, Arslan E, Abdel-Wahab R, Pazdrak B, Murthy R, Tahon NHM, Cho SN, Duose DY, Wani K, Liu J, Haymaker C, Gomez JA, Sonnemann H, Katailiha AS, Nassif-Rausseo B, Rahim M, Li I, Mayer AT, Yang X, Hsu FJ, Zhang J, Johnson DH, Amaria RN, Glitza Oliva IC, Patel SP, Hwu P, Elsayes KM, Tawbi HA, Burks JK, Bernatchez C, Davies MA , Rai K, Lizee G, Ekmekcioglu S, Diab A

Here's a breakdown of what the study found, how the protocol worked, and why this data matters

Theyre also very kind enough to give a bit of background on the compound, which you dont always see when it comes to research chemicals

Glucose metabolism modulation Studies suggest it may inhibit gluconeogenesis (glucose production in the liver) and enhance glycolysis (glucose breakdown), thereby potentially reducing blood glucose levels